Press release
Leading Element Driving Change in the Glomerulonephritis Market in 2025: Rising Prevalence Of Kidney Disorders Driving The Market Growth Driver
Glomerulonephritis
The growing prevalence of kidney disorders is projected to propel the glomerulonephritis market. Kidney disorders are conditions that affect the kidneys' structure or function, leading to impaired filtration, waste removal, and fluid balance. The rise in kidney disorders is due to factors such as an aging population, increasing chronic disease rates (like diabetes and hypertension), and lifestyle factors. Kidney disorders contribute to glomerulonephritis by triggering immune system dysfunction, chronic inflammation, or structural damage, which in turn impairs kidney function. For example, in December 2024, the Australian Institute of Health and Welfare reported that chronic kidney disease (CKD) mortality rates rose by 4.2% in 2021 and 6.2% in 2022. In the 2021-22 period, CKD was involved in approximately 2 million hospitalizations, accounting for 18% of all hospital admissions in Australia. Therefore, the growing prevalence of kidney disorders will drive the growth of the glomerulonephritis market.
Get Your Glomerulonephritis Market Report Here:
https://www.thebusinessresearchcompany.com/report/glomerulonephritis-global-market-report
What growth opportunities are expected to drive the glomerulonephritis market's CAGR through 2034?
The glomerulonephritis market has experienced strong growth, increasing from $11.06 billion in 2024 to $11.64 billion in 2025 at a CAGR of 5.3%. Growth factors include a rising prevalence of kidney disorders, increased cases of infections like post-streptococcal glomerulonephritis, greater investment in R&D, a rise in kidney failure cases, and improved awareness of kidney diseases.
The glomerulonephritis market is expected to grow steadily, reaching $14.14 billion by 2029 at a CAGR of 5.0%. Factors driving this growth include increasing cases of diabetes, an aging population, higher healthcare investments, a growing number of dialysis patients, and a rise in autoimmune diseases. Notable trends include the introduction of new treatments and therapies, advancements in diagnostic technologies, development of novel therapeutics, strategic collaborations between companies, and the adoption of intravenous immunoglobulin therapy.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp
What are the emerging trends shaping the future of the glomerulonephritis market?
In the glomerulonephritis market, companies are developing non-immunosuppressive treatments to treat kidney diseases without compromising immune function. One such treatment, FILSPARI (sparsentan), was introduced by Travere Therapeutics Inc., a US-based biopharmaceutical company, in September 2024. The FDA-approved drug is designed to treat IgA nephropathy, a kidney disease, and has shown significant promise in slowing the progression of kidney function decline, offering a non-immunosuppressive option for patients who previously had limited treatments.
Which growth-oriented segments of the glomerulonephritis market are leading the industry's development?
The glomerulonephritis market covered in this report is segmented -
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21193
What regions are leading the charge in the glomerulonephritis market?
North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the glomerulonephritis market?
Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp
What Is Covered In The Glomerulonephritis Global Market Report?
•Market Size Forecast: Examine the glomerulonephritis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the glomerulonephritis market for a structured understanding.
•Key Players Overview: Analyze major players in the glomerulonephritis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the glomerulonephritis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the glomerulonephritis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the glomerulonephritis market.
•Industry Challenges: Identify potential risks and obstacles affecting the glomerulonephritis market.
•Competitive Landscape: Review strategic developments in the glomerulonephritis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Glomerulonephritis Market in 2025: Rising Prevalence Of Kidney Disorders Driving The Market Growth Driver here
News-ID: 3934870 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Glomerulonephritis
Immune Complex Membranoproliferative Glomerulonephritis Market Forecast 2034
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) is a rare, chronic kidney disorder characterized by immune complex deposition in the glomeruli, leading to persistent inflammation, progressive renal damage, and potential progression to end-stage renal disease. Management relies on immunosuppressive therapy, biologics, supportive care, dialysis, and kidney transplantation in advanced cases.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70784
Market Size & Growth
• 2024 Market Value: ~USD 1.2 billion
• 2034 Market Forecast: ~USD 3.8 billion
• CAGR (2025-2034):…
Global Glomerulonephritis Market: Major Trends Reshaping the Future of the Indus …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Glomerulonephritis Industry Market Size Be by 2025?
The market for glomerulonephritis has experienced consistent expansion recently, projected to increase its valuation from $11.06 billion in 2024 to $11.61 billion the following year, reflecting a 4.9% compound annual growth rate. This historical upward trend is largely driven…
Glomerulonephritis Industry Report 2025-2034: Market Dynamics, Trends, And Forec …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Glomerulonephritis Market Size During the Forecast Period?
In recent years, the market size of glomerulonephritis has shown appreciable growth. It is predicted to escalate from $11.06 billion in 2024 to $11.64 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth…
Glomerulonephritis Market: An In-Depth Analysis
Glomerulonephritis is a condition affecting the kidneys, specifically the glomeruli, which are small blood vessels responsible for filtering waste from the blood. When these glomeruli become inflamed, it can lead to impaired kidney function. Glomerulonephritis can be caused by infections, autoimmune diseases, or other underlying health conditions. Its significance lies in its potential to cause chronic kidney disease (CKD) or end-stage renal failure if left untreated. With an increasing prevalence…
Glomerulonephritis Market to Grasp Outstanding CAGR of 4.70% by 2029
The glomerulonephritis market is expected to witness market growth at a rate of 4.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on glomerulonephritis market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in healthcare sector globally is escalating the growth of glomerulonephritis market.
Get Full Report: https://www.databridgemarketresearch.com/reports/global-glomerulonephritis-market
Glomerulonephritis…
Glomerulonephritis Treatment Market Set for Rapid Growth And Trend, by 2028
Glomerulonephritis Treatment Market: Introduction
Glomerulonephritis, also known as Bright's disease, is a progressive kidney disease that damages the glomeruli—the filtering units of the kidney that create urine as a waste. There are two types of glomerulonephritis, namely acute glomerulonephritis and chronic glomerulonephritis. The acute glomerulonephritis disease develops suddenly and can be caused by infections, such as strep throat. Acute glomerulonephritis disease can also be caused by infection in the throat or…
